Ajay Kumar Pal

Mr. Ajay Kumar Pal

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Stem Cells International
Verified
Journal Article
Open access
PDF file
APAnchal Pathak
Anchal Pathak
APAjay Kumar Pal
Ajay Kumar Pal
SRSubhadeep Roy
Subhadeep Roy
MNMukesh Nandave
Mukesh Nandave
KJKeerti Jain
Keerti Jain
Angiogenesis plays a significant role in the human body, from wound healing to tumor progression. “Angiogenic switch” indicates a time‐restricted event where the imbalance between pro‐ and antiangiogenic factors results in the transition from prevascular hyperplasia to outgrowing vascularized tumor, which eventually leads to the malignant cancer progression. In the last decade, molecular players, i.e., angiogenic biomarkers and underlying molecular pathways involved in tumorigenesis, have been intensely investigated. Disrupting the initiation and halting the progression of angiogenesis by targeting these biomarkers and molecular pathways has been considered as a potential treatment approach for tumor angiogenesis. This review discusses the currently known biomarkers and available antiangiogenic therapies in cancer, i.e., monoclonal antibodies, aptamers, small molecular inhibitors, miRNAs, siRNAs, angiostatin, endostatin, and melatonin analogues, either approved by the U.S. Food and Drug Administration or currently under clinical and preclinical investigations.

27 May 2022 in Pathophysiology
Verified
Journal Article
Open access
PDF file
APAjay Kumar Pal
Ajay Kumar Pal
PSPrateek Sharma
Prateek Sharma
AZAlishan Zia
Alishan Zia
DSDeepali Siwan
Deepali Siwan
DNDipali Nandave
Dipali Nandave
RGRupesh K Gautam
Rupesh K Gautam
Cancer cells undergo transient EMT and MET phenomena or vice versa, along with the parallel interplay of various markers, often correlated as the determining factor in decoding metabolic profiling of breast cancers. Moreover, various cancer signaling pathways and metabolic changes occurring in breast cancer cells modulate the expression of such markers to varying extents. The existing research completed so far considers the expression of such markers as determinants regulating the invasiveness and survival of breast cancer cells. Therefore, this manuscript is crosstalk among the expression levels of such markers and their correlation in regulating the aggressiveness and invasiveness of breast cancer. We also attempted to cover the possible EMT-based metabolic targets to retard migration and invasion of breast cancer.

8 July 2020 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
APAjay Kumar Pal
Ajay Kumar Pal
MNMukesh Nandave
Mukesh Nandave
GKGaurav Kaithwas
Gaurav Kaithwas

24 July 2024 in Trends in Immunotherapy
Verified
Journal Article
Open access
PDF file
SNSudhakar Nagarajan
Sudhakar Nagarajan
ADArun D.
Arun D.
DMDivya Jayalakshmi K. M.
Divya Jayalakshmi K. M.
PGPrem Shankar Gupta
Prem Shankar Gupta
APAjay Kumar Pal
Ajay Kumar Pal
SRSoniya Rani
Soniya Rani
With increasing environmental pollution (rising levels of air borne allergens) and smoke inhalational habits, biomass smoke, etc. all affect lung health, leading to various chronic lung diseases, and among them, life-threatening chronic obstructive pulmonary disease (COPD) is growing in prevalence around the globe. Thus, it’s a great demand from researchers to discover novel therapeutic drugs and vaccines against COPD. Human neutrophil elastase (HNE) is a major inflammatory protein that triggers inflammation in chronic airway diseases, causing airway remodeling and cytokines release. Recently, it has emerged as a significant target for drug discovery in patients with COPD. Hence, this study aimed to investigate the In-silico screening of the phytochemical medicinal plant Tridax procumbens against COPD via targeting HNE using the Schrodinger suite 2023-1. The docking score, glide score, and binding energy were calculated by the glide program using the Prime MM-GB/SA (Molecular Mechanics with Generalized Born and Surface Area Solvation) module. The best selected phytochemicals (ligands) were then screened for pharmacokinetic properties via ADMET analysis predicted using the qikProp program. Out of the library of Tridax procumbens, the phytochemicals like Apigetrin, Puerarin, Centaureidin, and Myricetin significantly bind to the catalytic site of HNE with PHE41, CYS42, SER195, GLY193, PHE192, HIS57, CYS58, PHE215, SER214, ASN61, LEU998, PRO98, TYR94, and ASP95 as residues with a glide score of the highest binding affinity (−7.707, −7.707, −7.045, and −6.871, respectively) compared to the standard drugs; Dexamethasone (−4.964), Roflumilast (−4.833), and Fluticasone (−3.968). The ADMET analysis of these four phytochemicals showed good pharmacokinetic profiles with human oral absorption, log S, molar volume, and van der waals volume, etc. Thus, In-silico findings suggest that carrying out these phytochemicals (Apigetrin, Puerarin, Centaureidin, and Myricetin) from Tridax procumbens to validate their therapeutic potential against COPD at preclinical and clinical levels.

12 April 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
VKVinay Kumar
Vinay Kumar
PVPriyanshi Varshney
Priyanshi Varshney
MTMohamad Taleuzzaman
Mohamad Taleuzzaman
RJRuqaiya Jamal
Ruqaiya Jamal
APAjay Kumar Pal
Ajay Kumar Pal
PPPallavi Mangesh Patil
Pallavi Mangesh Patil

11 November 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
GGGauri Goyal
Gauri Goyal
ADAbhijit Debnath
Abhijit Debnath
APAjay Kumar Pal
Ajay Kumar Pal
MTMohamad Taleuzzaman
Mohamad Taleuzzaman
KNK. Nagarajan
K. Nagarajan
VKVinay Kumar
Vinay Kumar